Skip to Main Content

You, the readers of STAT, have spoken. Your votes determined the best and worst biopharma CEOs of 2017.

The Best: John Maraganore of Alnylam Pharmaceuticals. Congratulations, John!

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

  • Hi, Adam. I have followed STAT’s reports on Dr. Soon-Shiong. As a former journalist, I am appalled that he has just bought the LA Times. The horse is probably out of the barn on that sale. But I’m wondering if you guys are planning to circle back and update the tale of his health care boondoggles….

Comments are closed.